Suppr超能文献

基于 MRM 的定量血浆蛋白质组学中的方法和平台标准化。

Method and platform standardization in MRM-based quantitative plasma proteomics.

机构信息

University of Victoria-Genome British Columbia Proteomics Centre, Vancouver Island Technology Park, #3101-4464 Markham St., Victoria, BC V8Z 7X8, Canada.

出版信息

J Proteomics. 2013 Dec 16;95:66-76. doi: 10.1016/j.jprot.2013.07.026. Epub 2013 Aug 7.

Abstract

UNLABELLED

There exists a growing demand in the proteomics community to standardize experimental methods and liquid chromatography-mass spectrometry (LC/MS) platforms in order to enable the acquisition of more precise and accurate quantitative data. This necessity is heightened by the evolving trend of verifying and validating candidate disease biomarkers in complex biofluids, such as blood plasma, through targeted multiple reaction monitoring (MRM)-based approaches with stable isotope-labeled standards (SIS). Considering the lack of performance standards for quantitative plasma proteomics, we previously developed two reference kits to evaluate the MRM with SIS peptide approach using undepleted and non-enriched human plasma. The first kit tests the effectiveness of the LC/MRM-MS platform (kit #1), while the second evaluates the performance of an entire analytical workflow (kit #2). Here, these kits have been refined for practical use and then evaluated through intra- and inter-laboratory testing on 6 common LC/MS platforms. For an identical panel of 22 plasma proteins, similar concentrations were determined, regardless of the kit, instrument platform, and laboratory of analysis. These results demonstrate the value of the kit and reinforce the utility of standardized methods and protocols.

BIOLOGICAL SIGNIFICANCE

The proteomics community needs standardized experimental protocols and quality control methods in order to improve the reproducibility of MS-based quantitative data. This need is heightened by the evolving trend for MRM-based validation of proposed disease biomarkers in complex biofluids such as blood plasma. We have developed two kits to assist in the inter- and intra-laboratory quality control of MRM experiments: the first kit tests the effectiveness of the LC/MRM-MS platform (kit #1), while the second evaluates the performance of an entire analytical workflow (kit #2). In this paper, we report the use of these kits in intra- and inter-laboratory testing on 6 common LC/MS platforms. This article is part of a Special Issue entitled: Standardization and Quality Control in Proteomics.

摘要

未标记

蛋白质组学领域越来越需要规范实验方法和液相色谱-质谱(LC/MS)平台,以便能够获取更精确和准确的定量数据。这种必要性因验证和验证候选疾病生物标志物在复杂生物流体(如血浆)中的趋势而加剧,方法是采用基于稳定同位素标记标准(SIS)的靶向多重反应监测(MRM)方法。考虑到定量血浆蛋白质组学缺乏性能标准,我们之前开发了两种参考试剂盒,用于评估使用未耗尽和非富集的人类血浆进行的 SIS 肽 LC/MRM-MS 方法的性能。第一个试剂盒测试 LC/MRM-MS 平台的有效性(试剂盒#1),而第二个试剂盒评估整个分析工作流程的性能(试剂盒#2)。在这里,这些试剂盒经过了改进,以便实际使用,然后通过在 6 个常见的 LC/MS 平台上进行内部和实验室间测试进行了评估。对于相同的 22 种血浆蛋白面板,无论试剂盒、仪器平台和分析实验室如何,都确定了相似的浓度。这些结果证明了试剂盒的价值,并强化了标准化方法和协议的实用性。

生物学意义

蛋白质组学领域需要标准化的实验方案和质量控制方法,以提高基于 MS 的定量数据的可重复性。这种需求因基于 MRM 的复杂生物流体(如血浆)中拟议疾病生物标志物验证的趋势而加剧。我们已经开发了两种试剂盒来协助 MRM 实验的实验室间和实验室内质量控制:第一个试剂盒测试 LC/MRM-MS 平台的有效性(试剂盒#1),而第二个试剂盒评估整个分析工作流程的性能(试剂盒#2)。在本文中,我们报告了在 6 个常见的 LC/MS 平台上进行的内部和实验室间测试中使用这些试剂盒的情况。本文是特刊题为“蛋白质组学中的标准化和质量控制”的一部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验